Insider Shareholders with Direct Ownership of Talaris Therapeutics, Inc. (TALS)
This section provides a comprehensive overview of the insiders with direct ownership of Talaris Therapeutics, Inc. (TALS). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Talaris Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Suzanne Ildstad
Director |
0 | 2,235,054 | 3,771,392 $10.3 Million | 23 |
Jun 14, 2023
Reduced 0.34%
|
| 729,735 | 0 | 729,735 $1.98 Million | 4 |
Nov 17, 2023
Added 0.55%
|
|
| 138,918 | 11,786 | 578,403 $1.57 Million | 8 |
Jul 03, 2023
Reduced 2.0%
|
|
|
Caley Castelein
Director |
516,519 | 0 | 516,519 $1.4 Million | 3 |
Oct 27, 2023
Added 2.97%
|
|
Nancy Krieger
Chief Medical Officer |
80,000 | 0 | 330,233 $898,233 | 1 |
Sep 10, 2022
Added 19.5%
|
|
Michael Zdanowski
Chief Technology Officer |
121,470 | 0 | 121,470 $330,398 | 2 |
Sep 10, 2022
Added 49.7%
|
|
Parvinder Thiara
Director |
83,782 | 0 | 83,782 $227,887 | 4 |
Nov 17, 2023
Added 1.18%
|
|
W Bradford Middlekauff
CBO, GC and Secretary |
69,201 | 0 | 69,201 $188,226 | 1 |
Oct 19, 2023
Added 50.0%
|
|
Mary Kay Fenton
Chief Financial Officer |
81,000 | 12,946 | 68,054 $185,106 | 3 |
Jul 03, 2023
Reduced 15.98%
|
|
Kevin Bruce Johnson
Chief Regulatory Officer |
57,834 | 0 | 57,834 $157,308 | 1 |
Oct 19, 2023
Added 50.0%
|
|
Yung H. Chyung
Chief Medical Officer |
56,836 | 0 | 56,836 $154,593 | 1 |
Oct 19, 2023
Added 50.0%
|
|
Aaron Kantoff
Director |
45,391 | 0 | 45,391 $123,463 | 2 |
Oct 24, 2023
Added 14.18%
|
|
Susan Dana Jones
Chief Technology Officer |
22,934 | 0 | 22,934 $62,380 | 1 |
Oct 19, 2023
Added 50.0%
|
|
Sapna Srivastava
Director |
518 | 0 | 518 $1,408 | 1 |
Oct 19, 2023
Added 50.0%
|
|
Mark Mcdade
Director |
518 | 0 | 518 $1,408 | 1 |
Oct 19, 2023
Added 50.0%
|
|
Francois Nader
Director |
138,500 | 138,500 | 0 $0 | 4 |
Jul 25, 2022
Reduced 100.0%
|